AHFS January 2026 update
This update contains 4 new monographs and 67 revised monographs.
New monographs: Elinzanetant;Doxecitine and Doxribtimine; Glycerol
Phenylbutyrate; Nerandomilast.
Revised monographs: Acarbose; Adefovir Dipivoxil; Alogliptin Benzoate; Anthrax
Immune Globulin IV (Human); Antimuscarinics/Antispasmodics General
Statement; Belimumab; Bictegravir Sodium, Emtricitabine, and Tenofovir
Alafenamide Fumarate; Brensocatib; Brentuximab Vedotin; Candesartan
Cilexetil; Caplacizumab-yhdp; CARBOplatin; Dehydrated Alcohol;
Delandistrogene Moxeparvovec-rokl; Dengue Vaccine Live; dilTIAZem
Hydrochloride; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate;
Elapegademase-lvlr; Elexacaftor, Tezacaftor, and Ivacaftor; Elivaldogene
Autotemcel; Exagamglogene Autotemcel; Fexinidazole; Fremanezumab-vfrm;
Gepotidacin Mesylate; Glecaprevir and Pibrentasvir; Hepatitis A Vaccine
Inactivated; Idecabtagene Vicleucel; Imipenem and Cilastatin Sodium; Ivacaftor;
L-Glutamine; Lisocabtagene Maraleucel; Lumacaftor and Ivacaftor; Mepolizumab;
Miglitol; Nemolizumab-ilto; Nevirapine; niCARdipine Hydrochloride;
Obecabtagene Autoleucel; Obiltoxaximab; Parathyroid Hormone; Pegaspargase;
Plasminogen, Human-tmvh; Poliovirus Vaccine Inactivated; Pomalidomide;
PrabotulinumtoxinA-xvfs; Pramlintide Acetate; Proparacaine Hydrochloride
(EENT); Prothrombin Complex Concentrate (Human); Raxibacumab; Rimegepant
Sulfate; Ropeginterferon Alfa-2b-njft; Semaglutide; SITagliptin; Smallpox and
Mpox (Vaccinia) Vaccine Live; Smallpox and Mpox Vaccine Live, Non-replicating;
Sodium Bicarbonate; SORAfenib Tosylate; Tezacaftor and Ivacaftor; Thyrotropin
Alfa; Trametinib Dimethyl Sulfoxide; Treprostinil; Vanzacaftor Calcium,
Tezacaftor, and Deutivacaftor; Varenicline Tartrate (EENT); Venetoclax;
Voclosporin; Zongertinib; Zoster Vaccine Recombinant, Adjuvanted.
